Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies

CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies

Researchers identify key characteristics associated with improved CAR T outcomes in large B cell lymphoma

Researchers identify key characteristics associated with improved CAR T outcomes in large B cell lymphoma

Aberrant RBMX expression relevant for cancer prognosis and immunotherapy response

Aberrant RBMX expression relevant for cancer prognosis and immunotherapy response

ATR inhibition using gartisertib in patient-derived glioblastoma cell lines

ATR inhibition using gartisertib in patient-derived glioblastoma cell lines

Special RNA suppresses the formation of breast cancer cells

Special RNA suppresses the formation of breast cancer cells

FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 stage III-IVA cervical cancer

FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 stage III-IVA cervical cancer

“Big data” analysis reveals new targets for treating ovarian cancer

“Big data” analysis reveals new targets for treating ovarian cancer

Research shows deadly brain cancer can mimic healthy neurons

Research shows deadly brain cancer can mimic healthy neurons

One more step towards treatment of PARP inhibitor-resistant ovarian cancers

One more step towards treatment of PARP inhibitor-resistant ovarian cancers

European Medicines Agency is looking at approving lazertinib, in combination with amivantamab, for the first-line treatment of patients with EGFR-mutated NSCLC

European Medicines Agency is looking at approving lazertinib, in combination with amivantamab, for the first-line...

More from ecancer